Revisiting Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: An Improved Computational Model
Revisiting Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: An Improved Computational Model
复制标题
重新审视药物样分子中醛氧化酶介导的代谢:改进的计算模型
DOI:
10.1021/acs.jmedchem.9b01895
复制
发表时间:
2020
影响因子:
7.3
通讯作者:
Zheng M.
中科院分区:
文献类型:
--
作者:
Zhao J.;Cui R.;Wang L.;Chen Y.;Fu Z.;Ding X.;Cui C.;Yang T.;Li X.;Xu Y.;Chen K.;Luo X.;Jiang H.;Zheng M.
Aldehyde oxidase (AOX) is a drug metabolizing molybdo-flavoenzyme that has gained increasing attention because of contribution to the biotransformation in phase I metabolism of xenobiotics. Unfortunately, the intra- and interspecies variations in AOX activity and lack of reliable and predictive animal models make evaluation of AOX-catalyzed metabolism prone to be misleading. In this study, we developed an improved computational model integrating both atom-level and molecule-level features to predict whether a drug-like molecule is a potential human AOX (hAOX) substrate and to identify the corresponding sites of metabolism. Additionally, we combined the proposed computational strategy and in vitro experiments for evaluating the metabolic property of a series of epigenetic-related drug candidates still in the early stage of development. In summary, this study provides an improved strategy to evaluate the liability of molecules toward hAOX and offers useful information for accelerating the drug design and optimization stage.